- VIR Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-3ASR Filing
Vir Biotechnology (VIR) S-3ASRAutomatic shelf registration
Filed: 3 Nov 23, 4:33pm
Exhibit 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
Vir Biotechnology, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type | Security Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial Effective Date | Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |||||||||||||
Newly Registered Securities | ||||||||||||||||||||||||
Fees to Be Paid | Debt | Debt Securities | 456(b) and 457(r) | (1) | (1) | (1) | (1) | (1) | — | — | — | — | ||||||||||||
Fees to Be Paid | Equity | Common Stock, par value $0.0001 per share | 456(b) and 457(r) | (1) | (1) | (1) | (1) | (1) | — | — | — | — | ||||||||||||
Fees to Be Paid | Equity | Preferred Stock | 456(b) and 457(r) | (1) | (1) | (1) | (1) | (1) | — | — | — | — | ||||||||||||
Fees to Be Paid | Equity | Warrants | 456(b) and 457(r) | (1) | (1) | (1) | (1) | (1) | — | — | — | — | ||||||||||||
Fees to Be Paid | Equity | Common Stock, par value $0.0001 per share | 457(o) | (1) | — | $0 (2) | — (2) | — (2) | — | — | — | — | ||||||||||||
Fees Previously Paid | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||||||
Carry Forward Securities | ||||||||||||||||||||||||
Carry Forward Securities | Equity | Common Stock, par value $0.0001 per share | 415(a)(6) | (2) | — | $300,000,000 | — | — | S-3 | 333-250013 | November 10, 2020 | $32,730 | ||||||||||||
Total Offering Amounts | $300,000,000(1)(2) | — | ||||||||||||||||||||||
Total Fees Previously Paid | — | |||||||||||||||||||||||
Total Fee Offsets | — | |||||||||||||||||||||||
Net Fee Due | — |
(1) Pursuant to Instruction 2.A(iii)(c) of Item 16(b) of Form S-3, this information is not required to be included. An indeterminate amount of the securities of each identified class is being registered as may from time to time be offered under this registration statement at indeterminate prices, along with an indeterminate number of securities that may be issued upon exercise, settlement, exchange or conversion of securities offered or sold under this registration statement. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also covers any additional securities that may be offered or issued in connection with any stock split, stock dividend or pursuant to anti-dilution provisions of any of the securities. Separate consideration may or may not be received for securities that are issuable upon conversion, exercise or exchange of other securities. In accordance with Rules 456(b) and 457(r) under the Securities Act, the registrant is deferring payment of all registration fees other than the registration fee due in connection with $300,000,000 of shares of common stock that may be issued and sold from time to time under the sales agreement prospectus included in this registration statement. Any registration fees will be paid subsequently on a pay-as-you-go basis.
(2) Pursuant to Rule 415(a)(6) under the Securities Act, the securities registered pursuant to this registration statement include $300,000,000 of unsold securities (the “Unsold Securities”) previously registered pursuant to the Registration Statement on Form S-3 (File No. 333-250013), which became effective on November 10, 2020 (the “Prior Registration Statement”). The Prior Registration Statement registered common stock for offerings under a sales agreement with Cowen and Company, LLC with a proposed maximum aggregate offering price of $300,000,000. The registrant did not sell any of such securities under the Prior Registration Statement, leaving the full $300,000,000 of Unsold Securities, in respect of which the registrant paid an aggregate registration fee of $32,730 (based on the filing fee rate in effect at the time of the filing of the Prior Registration Statement). Pursuant to Rule 415(a)(6), the filing fee of $32,730 associated with the offering of the Unsold Securities is hereby applied to offset the amount of the filing fee in connection with the $300,000,000 of securities registered hereunder. Pursuant to Rule 415(a)(6), the offering of the Unsold Securities under the Prior Registration Statement will be deemed terminated as of the time of filing of this registration statement.